Recruiting Ankylosing Spondylitis Studies in Glen Burnie
About Ankylosing Spondylitis Clinical Trials in Glen Burnie
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Glen Burnie, MD. These studies are seeking a combined 291 participants. Research is being sponsored by Eli Lilly and Company, University of Maryland, Baltimore. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Glen Burnie — FAQ
Are there ankylosing spondylitis clinical trials in Glen Burnie?
Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Glen Burnie, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Glen Burnie?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glen Burnie research site will contact you about next steps.
Are clinical trials in Glen Burnie free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glen Burnie studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 2 active trials in Glen Burnie are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated July 22, 2026 from ClinicalTrials.gov